2026 NPPES data Pharmacotherapy Pharmacist NPI 1760078364 RPH
Verify on CMS →

LEN DU, RPH

Pharmacotherapy Pharmacist in SAN JOSE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
186
Medicare Part D claims · 149 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
4%
generic claims · 96% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: LEN DU, RPH is a Pharmacotherapy Pharmacist ([object Object]) practicing in SAN JOSE, California with a Medicare Part D prescribing footprint of 186 claims across 149 beneficiaries — 96% brand-name prescribing .

What stands out: LEN DU, RPH filed 186 Medicare Part D claims in 2023 across SAN JOSE, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

LEN DU, RPH at a glance

Quality data not reported

NPI registry status

Active

Issued 12/17/2020

NPI 1760078364

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

186 53% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in California

How Pharmacotherapy Pharmacist compares to other specialties among California providers

California providers

Pharmacotherapy Pharmacist share within California

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LEN DU, RPH is a Pharmacotherapy Pharmacist provider practicing in SAN JOSE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: RPH. NPI: 1760078364. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

LEN DU, RPH appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding RPH credentials at 2643 SENTER RD STE A, SAN JOSE, CA, 95111, with a listed phone of (408) 287-4899. NPI 1760078364 was issued on 12/17/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 186 prescription claims written by this provider, covering 149 Medicare beneficiaries and totaling roughly $35K in drug spend, split 96% brand-name and 4% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2643 SENTER RD STE A
SAN JOSE, CA 95111

Provider Details

NPI 1760078364
Specialty Pharmacotherapy Pharmacist
Credentials RPH
Gender Male
NPI Issued 12/17/2020

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to LEN DU, RPH. To verify LEN DU, RPH's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

LEN DU, RPH — brand share 96.0%
Specialty average (est.)

96% brand-name claims vs 4% generic, on 186 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

186
Total Claims
$35K
Total Drug Cost
149
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
209
Total Day Supply
1,735
Brand vs Generic
96% brand / 4% generic
Brand Drug Cost
$35K

Patient Demographics

Average Patient Age
73.4 years
Avg HCC Risk Score
0.86
Gender Split
46% female / 54% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Shingrix
Varicella-Zoster Ge/As01b/Pf
114
Abrysvo
"Rsv Vacc
N/A
Boostrix Tdap
"Diphth
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How LEN DU, RPH fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

LEN DU, RPH's 186 claims are below the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as DU.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is LEN DU, RPH's specialty?
LEN DU, RPH specializes in Pharmacotherapy Pharmacist and practices in SAN JOSE, California. Credentials: RPH.
How much does LEN DU, RPH prescribe under Medicare Part D?
In 2023, LEN DU, RPH wrote 186 Medicare Part D claims totaling $35K in drug costs for 149 beneficiaries.
Where is LEN DU, RPH located?
LEN DU, RPH is located at 2643 SENTER RD STE A, SAN JOSE, CA, 95111. Phone: (408) 287-4899.
What is LEN DU, RPH's NPI number?
LEN DU, RPH's National Provider Identifier (NPI) is 1760078364, issued on 12/17/2020.
Does LEN DU, RPH prescribe more brand-name or generic drugs?
LEN DU, RPH's prescribing is 96% brand-name and 4% generic drugs by claim count, with $35K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does LEN DU, RPH prescribe most often?
Based on 2023 Medicare Part D data, LEN DU, RPH's most frequently prescribed drugs include Shingrix, Abrysvo, Boostrix Tdap. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LEN DU, RPH accept Medicare?
LEN DU, RPH appears in CMS Medicare data with 186 Part D claims and 149 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LEN DU, RPH's credentials?
LEN DU, RPH's NPI is 1760078364 with credentials RPH. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology